Latest National Diabetes Audit results published
Care of people with diabetes varies dramatically across England and Wales but there have been improvements nationally in all three key treatment targets, the latest National Diabetes Audit ...
Care of people with diabetes varies dramatically across England and Wales but there have been improvements nationally in all three key treatment targets, the latest National Diabetes Audit ...
Martin Hirst is the chief executive of the InDependent Diabetes Trust, a charity working to support people with diabetes. What are IDDT’s priorities for 2017? To continue to target teachers to ...
A pioneering research centre aimed at finding new treatments for type 2 diabetes will be built as part of a £115m collaboration between Novo Nordisk and a leading university. Novo Nordisk has ...
The type 2 drug Jardiance (empagliflozin) has become the first medication in the European Union to include cardiovascular death reduction data on the label. The newly approved information has ...
The role of the diabetes specialist nurse is hugely important in ensuring high-quality diabetes care. Our DSN Spotlight series celebrates this great position and also aims to find out more about ...
AstraZeneca’s two-drug therapy Qtern (saxagliptin and dapagliflozin fixed-dose combination) is now available in the UK for adults with type 2 diabetes. Saxagliptin and dapagliflozin ...
The use of continuous glucose monitoring (CGM) leads to a greater decrease in HbA1c levels compared with usual care, according to a new study. The DIaMonD study (Multiple Daily Injections and ...
People with type 1 diabetes have been invited to a meeting to help develop a new ‘whole person’ model of care for the condition. The Kaleidoscope approach aims to introduce a new cohesive, ...
Sanofi’s new insulin and GLP-1 combination Suliqua has received marketing approval from the European Commission. The once-daily treatment combines Lantus (insulin glargine) and with Lyxumia ...
Researchers are evaluating a structured lifestyle programme for women with type 2 diabetes. A research team King’s College London’s Florence Nightingale Faculty of Nursing and Midwifery are now ...